GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 19, 2012 | $2,120,000 | Replaced |
| 1st Quarter - Amendment | Jul 19, 2012 | $1,440,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 942 - American Research and Competitiveness Act of 2011- provisions relating to the research and development tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
S 1699 - Prescription Drug Cost Reduction Act - provisions related to Medicare Part B and drug rebates HR 999 - Medicare Prescription Drug Savings and Choice Act of 2011- provisions related to Medicare Part D HR 2190 - Medicare Drug Savings Act of 2011- provisions related to Medicare Part D HR 2248 - Medicare Prescription Drug Price Negotiation Act of 2011- provision related to Medicare Part D HR 3765 - Temporary Payroll Tax Cut Continuation Act of 2011- provisions related to Medicare S 31 - Prescription Drug and Health Improvement Act of 2011-provisions related to Medicare Part D S 44 - Medicare Prescription Drug Price Negotiation Act of 2011- provisions related to Medicare Part D HR 452 - Medicare Decisions Accountability Act - provisions related to the Independent Payment Advisory Board (IPAB) H.R. 5 - To improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system - provisions related to the Independent Payment Advisory Board (IPAB) S 560 - Medicare Prescription Drug Savings and Choice Act of 2011- provisions related to Medicare Part D S 668 - Health Care Bureaucrats Elimination Act - provisions related to the Independent Payment Advisory Board (IPAB) S 1206 - Medicare Prescription Drug Savings Act of 2011- provisions related to Medicare Part D S 1251 - Medicare and Medicaid FAST Act - provisions related to Part D issues H.R. 1063 - Strengthening Medicare & Repaying Taxpayers Act of 2011 - provisions relating to reform of Secondary Payer rules S 365 - Budget Control Act of 2011 - provisions related to deficit reduction through Medicare and Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Trade (domestic/foreign) TRD
Trans-Pacific Strategic Economic Partnership Agreement (TPP) - provisions related to intellectual property, market access and public health Russia Permanent Normal Trade Relations (PNTR) - "provisions related to lifting the restrictions of Title IV of the Trade Act of 1974 as they apply to Russia, which includes the freedom-of-emigration requirements of the Jackson-Vranik amendment."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
HR 3995 - Protect Consumers Access to Generic Drugs Act - provisions related to patent settlements S. 1882 - Fair and Immediate Release of Generic Drugs Act - provisions related to patent settlements HR 3497 - MODDERN Cures Act of 2011 - provisions related to data protection S 27 - Preserve Access to Affordable Generics Act - provisions related to patent settlements H.R. 741 - To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs - provisions relating to authorized generics HR 3261 - Stop Online Piracy Act - provisions related to anti-counterfeiting S 373 - The Fair Prescription Drug Competition Act - provisions related to authorized generics S 968 - Preventing Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 - provisions related to anti-counterfeiting HR 2182,S 1734 - Generating Antibiotic Incentives Now Act of 2011- provisions related to antibiotics and incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
S 2236 - Advancing Breakthrough Therapies for Patients Act of 2012 - provisions related to FDA regulation S 2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act - provisions related to accelerated approval and other FDA matters The Better Pharmaceuticals and Devices for Children Act - "Provisions related to o amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions" HR 4272 - BPCA and PREA Reauthorization Act of 2012 - Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act HR 4156, S 2281 - Expanding and Promoting Expertise in Rare Treatments Act of 2012 - provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases HR 3214 - Food and Drug Administration Mission Reform Act of 2011- provisions to revise the mission of the Food and Drug Administration HR 4132 - FAST Act - provisions related to accelerated approval and other FDA matters HR 3839 - Drug Shortage Prevention Act of 2012 - provisions related to prescription drug shortages HR 2674 - 340B Program Improvement Act - provisions related to the 340B program PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions HR 2405, S 1855 - Pandemic and All Hazards Preparedness Act - provisions relating to influenza vaccine innovative technologies HR 4223, S 1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) - provisions related to supply chain security HR 1483 - The Drug Safety Enhancement Act of 2011 - provisions related to supply chain security HR 1930, S 1799 - Access to Appropriate Immunizations for Veterans Act of 2011- provisions related to extending VA performance measure to include all federally recommended vaccine HR 3202 - Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S 3397 - Secure and Responsible Drug Disposal Act - provisions related to safe drug disposal S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 - provisions related to drug importation HR 2245, S 296 - Preserving Access to Life-Savings Medicines Act of 2011 - provisions related to drug shortages HR 2939 - Pharmaceutical Stewardship Act of 2011- provisions related to drug safety Prescription Drug User Fee Act - issues related to reauthorization of the Prescription Drug User Fee Act HR 2529, S 1368 - Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S 1584 - Drug Safety and Accountability Act of 2011- provisions related to drug safety Federal Food, Drug, and Cosmetic Act - section related to FDA and regulation of nicotine replacement therapies S. 1699 - Prescription Drug Cost Reduction Act - provisions related to 340B and drug rebates S. 1752 - Freedom to Breath Act of 2011 - provisions relating to the removal of Essential-Use Designation for epinephrine.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
Fiscal Year 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act - provisions relating to Ryan White CARE Act, FDA funding Fiscal Year 2013 Department of Homeland Security Appropriations Act - provisions relating to Customs and Border Protection Fiscal Year 2013 Labor-HHS-Education Appropriations Act - provisions relating to Vaccine Section 317 program, Ryan White CARE Act H Con Res 112 Establishing the budget for the United States Government for fiscal year 2013 and setting forth appropriate budgetary levels for fiscal years 2014 through 2022 - provisions related to health care programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.